Arthritis drug, Actemra, shows promising therapeutic value for COVID-19 patients
by Press Release from Outbreak News Today on (#52VR5)
UC San Diego Health has launched a Phase III clinical trial, part of a global effort, to assess whether a medication used to treat rheumatoid arthritis and other inflammatory disorders might also have therapeutic value for COVID-19 patients who have developed or at high risk of developing serious lung damage from SARS-CoV-2 infections. Tocilizumab, marketed [...]
The post Arthritis drug, Actemra, shows promising therapeutic value for COVID-19 patients appeared first on Outbreak News Today.